Single-cell immune profiling of Meniere Disease patients

This work was supported by B-CTS-68-UGR20 Grant by FEDER Funds, PI17/1644 and PI20-1126 grants from ISCIII by FEDER Funds from the EU, CLINMON-2 from the Meniere's Society UK, and Impact Data Science (IMP0001) . MF is funded by F18/00228 grant from ISCIII by FEDER Funds from the EU. AEB is funded by the EU's Horizon 2020 Research and Innovation Programme, Grant Agreement Number 848261. LF is funded by CD20/0153 grant from ISCIII by FEDER Funds from the EU. Funding for open access charge: Universidad de Granada/CBUA.Background: Meniere Disease (MD) is an inner ear syndrome, characterized by episodes of vertigo, tinnitus and fluctuating sensorineural hearing loss. The pathological mechanism leading to sporadic MD is still poorly understood, however an allergic inflammatory response seems to be involved in some patients with MD. Objective: Decipher an immune signature associated with the syndrome. Methods: We performed mass cytometry immune profiling on peripheral blood from MD patients and controls. We analyzed differences in state and differences in abundance of the different cellular subsets. IgE levels were quantified through ELISA on supernatant of cultured whole blood. Results: We have identified two clusters of individuals according to the single cell cytokine profile. These clusters presented differences in IgE levels, immune cell population abundance, including a reduction of CD56dim NKcells, and changes in cytokine expression with a different response to bacterial and fungal antigens. Conclusion: Our results support a systemic inflammatory response in some MD patients that show a type 2 response with allergic phenotype, which could benefit from personalized IL-4 blockers.FEDER Funds B-CTS-68-UGR20, B-CTS-68-UGR20Instituto de Salud Carlos III Spanish Government PI17/1644, PI20-1126, CD20/0153, 848261EUMeniere's Society UKImpact Data Science F18/00228Horizon 2020 IMP0001Universidad de Granada/CBU